Laser Interstitial Thermal Therapy Under "Real Time" MRI Guidance for "Minimal Invasive" Treatment of Liver Metastasis
NCT00392366 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 25
Last updated 2010-01-01
Summary
The purpose of this study is to determine if the, MR guided, laser interstitial thermal therapy (LITT) treatment technique can be safety and efficiently used for the human liver metastasis
Conditions
- Carcinoma, Hepatocellular
- Liver Neoplasms
- Digestive System Neoplasms
Interventions
- DEVICE
-
MR-guided Laser Interstitial Thermal Therapy System
Sponsors & Collaborators
-
BioTex, Inc.
lead INDUSTRY
Principal Investigators
-
Paul Legmann, M.D. · Cochin Hosptial, Paris, France
Study Design
- Allocation
- NON_RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
- Model
- SINGLE_GROUP
Eligibility
- Min Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2006-07-31
- Completion
- 2008-07-31
Countries
- France
Study Locations
More Related Trials
-
Microwave Ablation for the Treatment of Malignant Liver Tumors Closed to Intrahepatic Vessels
NCT03063840 ·Status: WITHDRAWN ·Phase: NA
-
Stereotactic Body Radiation Therapy in Liver Cancer That Cannot be Removed by Surgery or Transplant
NCT01194206 ·Status: WITHDRAWN ·Phase: PHASE2
-
Transarterial Chemoembolization (TACE) Versus TACE Plus Stereotactic Body Radiation Therapy (SBRT) in Liver Carcinoma
NCT03895359 ·Status: RECRUITING ·Phase: PHASE3
-
Combined Locoregional Treatment With Immunotherapy for Unresectable HCC.
NCT04220944 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE1
-
TheraSphere for the Treatment of Liver Metastases
NCT00511862 ·Status: COMPLETED ·Phase: PHASE2
-
Quality of Life in Patients Undergoing Embolization Using Yttrium Y 90 Glass Microspheres for Primary or Metastatic Liver Cancer
NCT00739167 ·Status: COMPLETED
-
A Trial on SBRT After Incomplete TAE or TACE Versus Exclusive TAE or TACE For Treatment of Inoperable HCC
NCT02323360 ·Status: TERMINATED ·Phase: NA
-
Heat Activated Liposomal Doxorubicin and Radiofrequency Ablation in Treating Patients With Primary or Metastatic Liver Tumors
NCT00093444 ·Status: COMPLETED ·Phase: PHASE1
-
Single Session Combined Locoregional Therapies for Hepatocellular Carcinoma
NCT02646137 ·Status: UNKNOWN ·Phase: PHASE3
-
Effectiveness of the Combined WLI and Hyperthermia for GI Cancer Liver Metastasis
NCT01963117 ·Status: TERMINATED ·Phase: NA
-
Drug-loadable(T-ACE Beads)for Hepatoma Embolization Therapy
NCT03299036 ·Status: COMPLETED ·Phase: NA
-
SBRT Plus Lenvatinib and TACE for Advanced Primary HCC: A Phase 3 Trial (SEARCH)
NCT05718232 ·Status: NOT_YET_RECRUITING ·Phase: PHASE3
-
Lenvatinib Plus Tislelizumab With or Without TACE in First-line Treatment of Unresectable HCC
NCT05842317 ·Status: RECRUITING ·Phase: PHASE1/PHASE2
-
Sorafenib and Micro-therapy Guided by Primovist Enhanced MRI in Patients With Inoperable Liver Cancer
NCT01126645 ·Status: COMPLETED ·Phase: PHASE2
-
Stereotactic Body Radiation Therapy (SBRT) vs Trans-Arterial Chemoembolization (TACE) as Bridge to Transplant
NCT03960008 ·Status: TERMINATED ·Phase: PHASE3
-
Stereotactic Body Radiotherapy for Hepatocellular Carcinoma, and Intrahepatic Cholangiocarcinoma
NCT01668134 ·Status: COMPLETED ·Phase: PHASE1
-
Stereotactic Body Radiotherapy and Surgery for Early-stage Hepatocellular Carcinoma
NCT03609151 ·Status: UNKNOWN ·Phase: NA
-
90Y Transarterial Radioembolization Versus Microwave Ablation in Small Hepatocellular Carcinoma With Hypoalbuminemia
NCT05953961 ·Status: RECRUITING ·Phase: NA
-
The Efficacy and Safety of EOB-MRI Guided Microwave Ablation for Early HCC: A Multicenter, Prospective, Observational Study
NCT06096896 ·Status: ACTIVE_NOT_RECRUITING
-
Radiofrequency-responsive Layered Double Hydroxides for Enhanced Arterial Embolization and Thermal Immunotherapy in Hepatocellular Carcinoma
NCT06966986 ·Status: ACTIVE_NOT_RECRUITING
-
Microwave Ablation of Resectable Liver Tumors
NCT00892255 ·Status: WITHDRAWN
-
A Study of Comparison of TACE Combination With and Without EBRT for Advanced HCC
NCT03116984 ·Status: UNKNOWN ·Phase: PHASE3
-
Ablation of Oligometastasis Combined With Lenvatinib and PD-1 Inhibitor for Advanced Hepatocellular Carcinoma
NCT06550921 ·Status: RECRUITING ·Phase: NA
-
Atezolizumab and Bevacizumab With Photon Radiotherapy for Unresectable Hepatocellular Carcinoma
NCT06339424 ·Status: RECRUITING ·Phase: PHASE2
-
Heat Therapy in Treating Patients With Unresectable Primary or Metastatic Liver Cancer
NCT00004136 ·Status: COMPLETED ·Phase: PHASE2